Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis

por Abu-Sbeih, Hamzah, Ali, Faisal S., Luo, Wenyi, Qiao, Wei, Raju, Gottumukkala S., Wang, Yinghong
Publicado en J Immunother Cancer (2018)

Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment

por Abu-Sbeih, Hamzah, Tran, Cynthia Nguyen, Ge, Phillip S., Bhutani, Manoop S., Alasadi, Mazen, Naing, Aung, Jazaeri, Amir A., Wang, Yinghong
Publicado en J Immunother Cancer (2019)

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

por Abu-Sbeih, Hamzah, Ali, Faisal S., Alsaadi, Dana, Jennings, Joseph, Luo, Wenyi, Gong, Zimu, Richards, David M., Charabaty, Aline, Wang, Yinghong
Publicado en J Immunother Cancer (2018)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

por Abu-Sbeih, Hamzah, Tang, Tenglong, Lu, Yang, Thirumurthi, Selvi, Altan, Mehmet, Jazaeri, Amir A., Dadu, Ramona, Coronel, Emmanuel, Wang, Yinghong
Publicado en J Immunother Cancer (2019)

Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia

por Abu-Sbeih, Hamzah, Ali, Faisal S., Qiao, Wei, Lum, Phillip, Shafi, Mehnaz A., Bresalier, Robert S., Hawk, Ernest, Raju, Gottumukkala S., Wang, Yinghong
Publicado en J Cancer (2020)

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

por Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Marie, Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Publicado en J Immunother Cancer (2019)

Patients with breast cancer may be at higher risk of colorectal neoplasia

por Abu-Sbeih, Hamzah, Ali, Faisal S., Ge, Phillip S., Barcenas, Carlos H., Lum, Phillip, Qiao, Wei, Bresalier, Robert S., Bhutani, Manoop S., Raju, Gottumukkala S., Wang, Yinghong
Publicado en Ann Gastroenterol (2019)

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis

por Abu-Sbeih, Hamzah, Herrera, Lauren Nicholas, Tang, Tenglong, Altan, Mehmet, Chaftari, Anne-Maria P., Okhuysen, Pablo C., Jenq, Robert R., Wang, Yinghong
Publicado en J Immunother Cancer (2019)

Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy

por Abu-Sbeih, Hamzah, Mallepally, Niharika, Goldstein, Ryan, Chen, Ellie, Tang, Tenglong, Dike, Uzoamaka K., Al-Asadi, Mazen, Westin, Shannon, Halperin, Daniel, Wang, Yinghong
Publicado en J Cancer (2020)

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

por Wang, Yinghong, Abu-Sbeih, Hamzah, Mao, Emily, Ali, Noman, Ali, Faisal Shaukat, Qiao, Wei, Lum, Phillip, Raju, Gottumukkala, Shuttlesworth, Gladis, Stroehlein, John, Diab, Adi
Publicado en J Immunother Cancer (2018)

Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity?

por Choi, Kati, Abu-Sbeih, Hamzah, Samdani, Rashmi, Nogueras Gonzalez, Graciela, Raju, Gottumukkala Subba, Richards, David M, Gao, Jianjun, Subudhi, Sumit, Stroehlein, John, Wang, Yinghong
Publicado en Inflamm Bowel Dis (2019)

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis

por Abu-Sbeih, Hamzah, Ali, Faisal S., Wang, Xuemei, Mallepally, Niharika, Chen, Ellie, Altan, Mehmet, Bresalier, Robert S., Charabaty, Aline, Dadu, Ramona, Jazaeri, Amir, Lashner, Bret, Wang, Yinghong
Publicado en J Immunother Cancer (2019)

Clinical characteristics of colitis induced by taxane-based chemotherapy

por Chen, Ellie, Abu-Sbeih, Hamzah, Thirumurthi, Selvi, Mallepally, Niharika, Khurana, Shruti, Wei, Dongguang, Altan, Mehmet, Morris, Van K., Tan, Dongfeng, Barcenas, Carlos H., Wang, Yinghong
Publicado en Ann Gastroenterol (2020)

Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort

por Pomenti, Sydney, Gandle, Cassandra, Abu Sbeih, Hamzah, Phipps, Meaghan, Livanos, Alexandra, Guo, Averill, Yeh, Jonathan, Burney, Heather, Liu, Hao, Dakhoul, Lara, Kettler, Carla, Gawrieh, Samer, deLemos, Andrew, Scanga, Andrew, Chalasani, Naga, Miller, Ethan, Wattacheril, Julia
Publicado en Hepatol Commun (2020)

Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate

por Raju, Gottumukkala S., Lum, Phillip, Abu-Sbeih, Hamzah, Ross, William A., Thirumurthi, Selvi, Miller, Ethan, Lynch, Patrick, Lee, Jeffrey, Bhutani, Manoop S., Shafi, Mehnaz, Weston, Brian, Rashid, Asif, Wang, Yinghong, Chang, George J., Carlson, Richard, Hagan, Katherine, Davila, Marta, Stroehlein, John
Publicado en Endosc Int Open (2020)

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

por Abu-Sbeih, Hamzah, Ali, Faisal S., Naqash, Abdul Rafeh, Owen, Dwight H., Patel, Sandipkumar, Otterson, Gregory A., Kendra, Kari, Ricciuti, Biagio, Chiari, Rita, De Giglio, Andrea, Sleiman, Joseph, Funchain, Pauline, Wills, Beatriz, Zhang, Jiajia, Naidoo, Jarushka, Philpott, Jessica, Gao, Jianjun, Subudhi, Sumit K., Wang, Yinghong
Publicado en J Clin Oncol (2019)

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

por Johnson, Daniel H, Zobniw, Chrystia M, Trinh, Van A, Ma, Junsheng, Bassett, Roland L, Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E, Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C, Davies, Michael A, Wong, Michael K, Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi
Publicado en J Immunother Cancer (2018)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

por Brahmer, Julie R, Abu-Sbeih, Hamzah, Ascierto, Paolo Antonio, Brufsky, Jill, Cappelli, Laura C, Cortazar, Frank B, Gerber, David E, Hamad, Lamya, Hansen, Eric, Johnson, Douglas B, Lacouture, Mario E, Masters, Gregory A, Naidoo, Jarushka, Nanni, Michele, Perales, Miguel-Angel, Puzanov, Igor, Santomasso, Bianca D, Shanbhag, Satish P, Sharma, Rajeev, Skondra, Dimitra, Sosman, Jeffrey A, Turner, Michelle, Ernstoff, Marc S
Publicado en J Immunother Cancer (2021)

Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

por Johnson, Daniel H., Zobniw, Chrystia M., Trinh, Van A., Ma, Junsheng, Bassett Jr, Roland L., Abdel-Wahab, Noha, Anderson, Jaime, Davis, Jennifer E., Joseph, Jocelyn, Uemura, Marc, Noman, Ali, Abu-Sbeih, Hamzah, Yee, Cassian, Amaria, Rodabe, Patel, Sapna, Tawbi, Hussein, Glitza, Isabella C., Davies, Michael A., Wong, Michael K., Woodman, Scott, Hwu, Wen-Jen, Hwu, Patrick, Wang, Yinghong, Diab, Adi
Publicado en J Immunother Cancer (2019)

Fecal Microbiota Transplantation for refractory immune checkpoint inhibitor-associated colitis

por Wang, Yinghong, Wiesnoski, Diana H., Helmink, Beth A., Gopalakrishnan, Vancheswaran, Choi, Kati, DuPont, Hebert L., Jiang, Zhi-Dong, Abu-Sbeih, Hamzah, Sanchez, Christopher A., Chang, Chia-Chi, Parra, Edwin R., Francisco-Cruz, Alejandro, Raju, Gottumukkala S., Stroehlein, John R., Campbell, Matthew T., Gao, Jianjun, Subudhi, Sumit K., Maru, Dipen M., Blando, Jorge M., Lazar, Alexander, Allison, James P., Sharma, Padmanee, Tetzlaff, Michael T., Wargo, Jennifer A., Jenq, Robert R.
Publicado en Nat Med (2018)